Michael Petusky

Stock Analyst at Barrington Research

(0.05)
# 2111
Out of 5,240 analysts
176
Total ratings
45.52%
Success rate
0.38%
Average return
19 Stocks
Name Action Price Target Current % Upside Ratings Updated
Option Care Health
Maintains: Outperform
32 33
28.76 14.74% 12 Jan 14, 2025
ModivCare
Maintains: Outperform
25 10
5.91 69.2% 13 Jan 14, 2025
Merit Medical System...
Maintains: Outperform
114 114
99.92 14.09% 16 Dec 23, 2024
Haemonetics
Maintains: Outperform
108 108
79.91 35.15% 22 Dec 4, 2024
US Physical Therapy
Maintains: Outperform
108 108
88.57 21.94% 21 Nov 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
2 2
3.23 -53.56% 8 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
3 3
1.47 53.06% 9 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
36 24
18.02 33.19% 17 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
82 82
71.25 15.09% 11 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
92 93
95.83 -2.95% 8 Nov 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
37 25
15.59 60.36% 15 Nov 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 6 Aug 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 6 May 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
14 12
n/a n/a 6 Oct 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Jul 27, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
14
n/a n/a 1 Jun 9, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 2 Dec 18, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 1 Aug 3, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 1 Aug 11, 2016